Search Results 51-60 of 16751 for Hepatic steatosis
The primary aim of this study is to determine the accuracy of CAP from Fibroscan in the quantification of liver steatosis in donors using liver biopsies as the ...
Most liver cysts can be seen on ultrasound or CT scans. When needed, treatment may include drainage or removal of the cyst.
Nonalcoholic fatty liver disease. · Chronic hepatitis B or C. · Autoimmune hepatitis. · Liver cirrhosis. · Primary biliary cholangitis. · Primary sclerosing ...
Since type 2 diabetes and non-alcoholic fatty liver disease are associated with metabolism, understanding the mechanisms that drive these cellular cargo trucks ...
People with this blood sugar disorder have a greater risk of liver cancer than those who don't have diabetes. Nonalcoholic fatty liver disease. An accumulation ...
The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.
Obesity is a key risk factor in the development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Both of these conditions ...
Patients taking medications known to cause hepatic steatosis will be excluded. Note: Other protocol defined Inclusion/Exclusion criteria may apply ...
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies. Biol Sex Differ. 2021 Mar 25; 12 (1): ...
Obesity can cause a condition called nonalcoholic fatty liver disease, which may include fatty liver, hepatitis and cirrhosis. The Mayo Clinic experience and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.